Confo Therapeutics
Ghent, Belgium · Founded 2015 · $67.1M raised
- Headquarters
- Ghent
- Founded
- 2015
- Website
- confotherapeutics.com
- Total Funding
- $67.1M
- Last Round
- $33.5M Series AMay 2019
- Rounds
- 2
About
Biotech company developing novel GPCR-targeting therapeutics using conformation-specific nanobodies.
Summary
Confo Therapeutics is a Biotechnology company based in Ghent, Belgium, founded in 2015. It has raised $67.1M in total across 2 rounds, most recently a $33.5M Series A round in May 2019.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2019
Sign up to see all 2 rounds
Series A — per-round amounts, valuations, and who invested in each round.
Similar Companies
Novel vaccine platform
Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...
Small molecule therapies for cardiovascular diseases
Breakthrough technology for the oral delivery of biologics
BridgeBio makes targeted treatments for genetic diseases.
Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/confo-therapeutics"><img src="https://indexed.vc/api/badge/company/confo-therapeutics" alt="Confo Therapeutics on Indexed.vc" width="260" height="76" /></a>